{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:26:14Z","timestamp":1792553174998,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,9]],"date-time":"2027-03-09T00:00:00Z","timestamp":1804550400000},"content-version":"am","delay-in-days":373,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA257195"],"award-info":[{"award-number":["R01CA257195"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA254104"],"award-info":[{"award-number":["R01CA254104"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01CA284085"],"award-info":[{"award-number":["U01CA284085"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000884","name":"Cancer Research Institute","doi-asserted-by":"publisher","award":["CRI4641"],"award-info":[{"award-number":["CRI4641"]}],"id":[{"id":"10.13039\/100000884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020424","name":"Weill Cornell Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020424","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000953","name":"Alliance for Cancer Gene Therapy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000953","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019368","name":"The Applebaum Foundation Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019368","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ccell.2025.12.021","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T16:27:44Z","timestamp":1769099264000},"page":"534-550.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvironment and control metastatic cancer growth"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6591-379X","authenticated-orcid":false,"given":"Jaime","family":"Mateus-Tique","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwitha","family":"Lakshmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavya","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhea","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso R.","family":"S\u00e1nchez-Paulete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Falcomat\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gvantsa","family":"Pantsulaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Tepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trung","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Amabile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurkan","family":"Mollaoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisanna","family":"Pia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Chhamalwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Le Berichel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hunter","family":"Potak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Colonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Baccarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Brody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4481-7827","authenticated-orcid":false,"given":"Miriam","family":"Merad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3670-8778","authenticated-orcid":false,"given":"Brian D.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2025.12.021_bib1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMra1706169","article-title":"Chimeric Antigen Receptor Therapy","volume":"379","author":"June","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ccell.2025.12.021_bib2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","article-title":"CAR-T cell therapy: current limitations and potential strategies","volume":"11","author":"Sterner","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.ccell.2025.12.021_bib3","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/s41573-023-00807-1","article-title":"Mechanisms of resistance to chimeric antigen receptor-T cells in haematological malignancies","volume":"22","author":"Ruella","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ccell.2025.12.021_bib4","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1158\/2159-8290.CD-18-0442","article-title":"Tumor Antigen Escape from CAR T-cell Therapy","volume":"8","author":"Majzner","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2025.12.021_bib5","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/mt.2010.24","article-title":"Case report of a serious adverse event following the administration of t cells transduced with a chimeric antigen receptor recognizing ERBB2","volume":"18","author":"Morgan","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ccell.2025.12.021_bib6","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3389\/fimmu.2020.01109","article-title":"CAR-T Cells Hit the Tumor Microenvironment: Strategies to Overcome Tumor Escape","volume":"11","author":"Rodriguez-Garcia","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ccell.2025.12.021_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-Associated Macrophages: From Mechanisms to Therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2025.12.021_bib8","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ccell.2019.02.009","article-title":"Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets","volume":"35","author":"Cassetta","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2025.12.021_bib9","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41586-021-03651-8","article-title":"Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells","volume":"595","author":"Casanova-Acebes","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.12.021_bib10","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ccell.2024.04.002","article-title":"A temporal perspective for tumor-associated macrophage identities and functions","volume":"42","author":"Bl\u00e9riot","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2025.12.021_bib11","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.1158\/0008-5472.CAN-09-4672","article-title":"Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes","volume":"70","author":"Movahedi","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2025.12.021_bib12","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.cell.2020.06.032","article-title":"Coupled scRNA-Seq and Intracellular Protein Activity Reveal an Immunosuppressive Role of TREM2 in Cancer","volume":"182","author":"Katzenelenbogen","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.12.021_bib13","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41590-023-01475-4","article-title":"TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer","volume":"24","author":"Park","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ccell.2025.12.021_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101739","article-title":"TREM2: A new player in the tumor microenvironment","volume":"67","author":"Molgora","year":"2023","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.ccell.2025.12.021_bib15","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s41467-021-20893-2","article-title":"CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy","volume":"12","author":"Rodriguez-Garcia","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2025.12.021_bib16","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1245\/s10434-012-2263-0","article-title":"Clinical significance of folate receptor \u03b2-expressing tumor-associated macrophages in pancreatic cancer","volume":"19","author":"Kurahara","year":"2012","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.ccell.2025.12.021_bib17","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.ccell.2021.10.009","article-title":"Single-cell analysis of human non-small cell lung cancer lesions refines tumor classification and patient stratification","volume":"39","author":"Leader","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2025.12.021_bib18","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.cell.2017.04.014","article-title":"Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses","volume":"169","author":"Lavin","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.12.021_bib19","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.cell.2022.02.021","article-title":"Tissue-resident FOLR2+ macrophages associate with CD8+ T cell infiltration in human breast cancer","volume":"185","author":"Nalio Ramos","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.12.021_bib20","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3390\/cancers11091315","article-title":"TREM2 Acts as a Tumor Suppressor in Colorectal Carcinoma through Wnt1\/\u03b2-catenin and Erk Signaling","volume":"11","author":"Kim","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ccell.2025.12.021_bib21","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1158\/1078-0432.CCR-16-3261","article-title":"First-in-Human Study of AMG 820, a Monoclonal Anti-Colony-Stimulating Factor 1 Receptor Antibody, in Patients with Advanced Solid Tumors","volume":"23","author":"Papadopoulos","year":"2017","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.ccell.2025.12.021_bib22","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/annonc\/mdz163","article-title":"Phase I study of emactuzumab single agent or in combination with paclitaxel in patients with advanced\/metastatic solid tumors reveals depletion of immunosuppressive M2-like macrophages","volume":"30","author":"Gomez-Roca","year":"2019","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.ccell.2025.12.021_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40425-017-0257-y","article-title":"Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy","volume":"5","author":"Cannarile","year":"2017","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ccell.2025.12.021_bib24","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1158\/2159-8290.CD-16-0850","article-title":"Overcoming the Immunosuppressive Tumor Microenvironment of Hodgkin Lymphoma Using Chimeric Antigen Receptor T Cells","volume":"7","author":"Ruella","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2025.12.021_bib25","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1158\/2326-6066.CIR-21-1075","article-title":"Targeting Macrophages with CAR T Cells Delays Solid Tumor Progression and Enhances Antitumor Immunity","volume":"10","author":"S\u00e1nchez-Paulete","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ccell.2025.12.021_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-10940-8","article-title":"Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment","volume":"7","author":"Yeku","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ccell.2025.12.021_bib27","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/carcin\/21.4.585","article-title":"Development of a syngeneic mouse model for events related to ovarian cancer","volume":"21","author":"Roby","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ccell.2025.12.021_bib28","doi-asserted-by":"crossref","first-page":"7492","DOI":"10.1016\/j.cell.2024.10.006","article-title":"Ovarian cancer-derived IL-4 promotes immunotherapy resistance","volume":"187","author":"Mollaoglu","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.12.021_bib29","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00262-009-0667-x","article-title":"Targeting tumor-associated macrophages in an experimental glioma model with a recombinant immunotoxin to folate receptor beta","volume":"58","author":"Nagai","year":"2009","journal-title":"Cancer Immunol. Immunother. CII"},{"key":"10.1016\/j.ccell.2025.12.021_bib30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1073\/pnas.2637010100","article-title":"Shifting foci of hematopoiesis during reconstitution from single stem cells","volume":"101","author":"Cao","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2025.12.021_bib31","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0092-8674(92)90030-G","article-title":"RAG-1-deficient mice have no mature B and T lymphocytes","volume":"68","author":"Mombaerts","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.12.021_bib32","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1158\/0008-5472.CAN-08-0045","article-title":"Interleukin-15\/Interleukin-15R\u03b1 Complexes Promote Destruction of Established Tumors by Reviving Tumor-Resident CD8+ T Cells","volume":"68","author":"Epardaud","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2025.12.021_bib33","doi-asserted-by":"crossref","first-page":"71249","DOI":"10.18632\/oncotarget.19531","article-title":"Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy","volume":"8","author":"Medrano","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ccell.2025.12.021_bib34","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.cell.2006.07.025","article-title":"A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules","volume":"126","author":"Banaszynski","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.12.021_bib35","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1126\/science.ade2292","article-title":"CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers","volume":"381","author":"Bill","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.ccell.2025.12.021_bib36","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41586-025-09754-w","article-title":"Tumour-reactive heterotypic CD8 T cell clusters from clinical samples","volume":"649","author":"Ib\u00e1\u00f1ez-Molero","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.12.021_bib37","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1158\/2159-8290.CD-20-0756","article-title":"A Critical Role for Fas-Mediated Off-Target Tumor Killing in T-cell Immunotherapy","volume":"11","author":"Upadhyay","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2025.12.021_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109844","article-title":"Targeting TREM2 on tumor-associated macrophages enhances immunotherapy","volume":"37","author":"Binnewies","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.ccell.2025.12.021_bib39","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.cell.2020.07.013","article-title":"TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy","volume":"182","author":"Molgora","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.12.021_bib40","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1182\/blood-2011-12-400044","article-title":"Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning","volume":"119","author":"Pegram","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2025.12.021_bib41","doi-asserted-by":"crossref","DOI":"10.4161\/2162402X.2014.994446","article-title":"IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumors in vivo","volume":"4","author":"Koneru","year":"2015","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ccell.2025.12.021_bib42","doi-asserted-by":"crossref","first-page":"5697","DOI":"10.1158\/0008-5472.CAN-11-0103","article-title":"IL-12 Release by Engineered T Cells Expressing Chimeric Antigen Receptors Can Effectively Muster an Antigen-Independent Macrophage Response on Tumor Cells That Have Shut Down Tumor Antigen Expression","volume":"71","author":"Chmielewski","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2025.12.021_bib43","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12967-015-0460-x","article-title":"A phase I clinical trial of adoptive T cell therapy using IL-12 secreting MUC-16ecto directed chimeric antigen receptors for recurrent ovarian cancer","volume":"13","author":"Koneru","year":"2015","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ccell.2025.12.021_bib44","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ygyno.2020.06.089","article-title":"A phase I clinical trial of autologous chimeric antigen receptor (CAR) T cells genetically engineered to secrete IL-12 and to target the MUC16ecto antigen in patients (pts) with MUC16ecto+ recurrent high-grade serous ovarian cancer (HGSOC)","volume":"159","author":"O\u2019Cearbhaill","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ccell.2025.12.021_bib45","doi-asserted-by":"crossref","first-page":"9395","DOI":"10.1158\/0008-5472.CAN-09-2050","article-title":"Folate Receptor \u03b2 Is Expressed by Tumor-Associated Macrophages and Constitutes a Marker for M2 Anti-inflammatory\/Regulatory Macrophages","volume":"69","author":"Puig-Kr\u00f6ger","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2025.12.021_bib46","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1158\/0008-5472.CAN-20-1414","article-title":"Folate Receptor Beta Designates Immunosuppressive Tumor-Associated Myeloid Cells That Can Be Reprogrammed with Folate-Targeted Drugs","volume":"81","author":"Cresswell","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2025.12.021_bib47","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41392-020-0115-0","article-title":"Targeting folate receptor \u03b2 positive tumor-associated macrophages in lung cancer with a folate-modified liposomal complex","volume":"5","author":"Tie","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ccell.2025.12.021_bib48","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202000935","article-title":"Pancreatic cancer is marked by complement-high blood monocytes and tumor-associated macrophages","volume":"4","author":"Kemp","year":"2021","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.ccell.2025.12.021_bib49","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3390\/vaccines10060943","article-title":"Exploring the Impact of TREM2 in Tumor-Associated Macrophages","volume":"10","author":"Khantakova","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.ccell.2025.12.021_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314563","article-title":"Joining Forces for Cancer Treatment: From \u201cTCR versus CAR\u201d to \u201cTCR and CAR.\u201d","volume":"23","author":"Teppert","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ccell.2025.12.021_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abe2606","article-title":"Comparative analysis of TCR and CAR signaling informs CAR designs with superior antigen sensitivity and in vivo function","volume":"14","author":"Salter","year":"2021","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ccell.2025.12.021_bib52","first-page":"1088","article-title":"Comparison of T Cell Activities Mediated by Human TCRs and CARs That Use the Same Recognition Domains","volume":"200","author":"Harris","year":"2018","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.ccell.2025.12.021_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101033","article-title":"Efficient killing of tumor cells by CAR-T cells requires greater number of engaged CARs than TCRs","volume":"297","author":"Anikeeva","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ccell.2025.12.021_bib54","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1074-7613(00)80483-5","article-title":"Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response","volume":"4","author":"Sykulev","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2025.12.021_bib55","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ccell.2025.12.021_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114773","article-title":"BTN2A1 targeting reprograms M2-like macrophages and TAMs via SYK and MAPK signaling","volume":"43","author":"Kerneur","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.ccell.2025.12.021_bib57","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ccell.2025.12.021_bib58","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.bjc.6690118","article-title":"Induction of reactive oxygen intermediates in human monocytes by tumour cells and their role in spontaneous monocyte cytotoxicity","volume":"79","author":"Mytar","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ccell.2025.12.021_bib59","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7095902","article-title":"NOX2-Derived Reactive Oxygen Species in Cancer","volume":"2020","author":"Grauers Wiktorin","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ccell.2025.12.021_bib60","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1158\/1078-0432.CCR-11-3050","article-title":"Local Delivery of lnterleukin-12 Using T Cells Targeting VEGF Receptor-2 Eradicates Multiple Vascularized Tumors in Mice","volume":"18","author":"Chinnasamy","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2025.12.021_bib61","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1158\/1078-0432.CCR-14-2085","article-title":"Tumor-infiltrating lymphocytes genetically engineered with an inducible gene encoding interleukin-12 for the immunotherapy of metastatic melanoma","volume":"21","author":"Zhang","year":"2015","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.ccell.2025.12.021_bib62","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ymthe.2017.02.014","article-title":"The Balance between CD8+ T Cell-Mediated Clearance of AAV-Encoded Antigen in the Liver and Tolerance Is Dependent on the Vector Dose","volume":"25","author":"Kumar","year":"2017","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.ccell.2025.12.021_bib63","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1600-065X.2006.00435.x","article-title":"Cellular and molecular mechanisms of liver tolerance","volume":"213","author":"Crispe","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ccell.2025.12.021_bib64","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jhep.2016.05.037","article-title":"Bone marrow-derived and resident liver macrophages display unique transcriptomic signatures but similar biological functions","volume":"65","author":"Beattie","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ccell.2025.12.021_bib65","first-page":"409","article-title":"Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies","volume":"3","author":"Atkins","year":"1997","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.ccell.2025.12.021_bib66","first-page":"2541","article-title":"Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production","volume":"90","author":"Leonard","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2025.12.021_bib67","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.ccell.2022.11.006","article-title":"Expression of inducible factors reprograms CAR-T cells for enhanced function and safety","volume":"40","author":"Smole","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2025.12.021_bib68","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1182\/blood-2004-11-4564","article-title":"An inducible caspase 9 safety switch for T-cell therapy","volume":"105","author":"Straathof","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2025.12.021_bib69","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41592-019-0371-5","article-title":"In vivo profiling of metastatic double knockouts through CRISPR\u2013Cpf1 screens","volume":"16","author":"Chow","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ccell.2025.12.021_bib72","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00262-009-0667-x","article-title":"Targeting tumor-associated macrophages in an experimental glioma model with a recombinant immunotoxin to folate receptor \u03b2","volume":"58","author":"Nagai","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ccell.2025.12.021_bib73","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nbt0197-35","article-title":"Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo","volume":"15","author":"Lieschke","year":"1997","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2025.12.021_bib74","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1074\/jbc.M508624200","article-title":"Soluble Interleukin-15 Receptor \u03b1 (IL-15R\u03b1)-sushi as a Selective and Potent Agonist of IL-15 Action through IL-15R\u03b2\/\u03b3","volume":"281","author":"Mortier","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ccell.2025.12.021_bib76","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.celrep.2015.01.040","article-title":"Transcriptome Analysis of Individual Stromal Cell Populations Identifies Stroma-Tumor Crosstalk in Mouse Lung Cancer Model","volume":"10","author":"Choi","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.ccell.2025.12.021_bib77","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.cell.2014.12.021","article-title":"Organoid models of human and mouse ductal pancreatic cancer","volume":"160","author":"Boj","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.12.021_bib78","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s40425-019-0654-5","article-title":"Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancer","volume":"7","author":"Hartl","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ccell.2025.12.021_bib79","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.4049\/jimmunol.177.6.3520","article-title":"Cutting Edge: TREM-2 Attenuates Macrophage Activation","volume":"177","author":"Turnbull","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.ccell.2025.12.021_bib80","doi-asserted-by":"crossref","DOI":"10.3791\/64253-v","article-title":"Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer","author":"Schmitt","year":"2022","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ccell.2025.12.021_bib70","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/978-1-4939-9773-2_23","article-title":"Multiplexed Immunohistochemical Consecutive Staining on Single Slide (MICSSS): Multiplexed Chromogenic IHC Assay for High-Dimensional Tissue Analysis","volume":"2055","author":"Akturk","year":"2020","journal-title":"Methods Mol. Biol. Clifton NJ"},{"key":"10.1016\/j.ccell.2025.12.021_bib71","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.cell.2022.02.015","article-title":"Spatial CRISPR genomics identifies regulators of the tumor microenvironment","volume":"185","author":"Dhainaut","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.12.021_bib81","volume":"bioRxiv","author":"Falcomat\u00e0","year":"2025","journal-title":"Plasminogen activator inhibitors orchestrate the immunosuppressive tumor microenvironment in pancreatic cancer"}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610825005550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610825005550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:26:36Z","timestamp":1791347196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610825005550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":80,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1535610825005550"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2025.12.021","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvironment and control metastatic cancer growth","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2025.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2025.11.009","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}